Impact of Vitamin D deficiency on subclinical carotid atherosclerosis: A pooled analysis of cohort studies

Journal of Clinical Endocrinology and Metabolism

Volumn 102, Issue 7, 2017, Pages 2146-2153

  Lupoli, Roberta ^a   Vaccaro, Andrea ^a   Ambrosino, Pasquale ^a   Poggio, Paolo ^b   Amato, Manuela ^b   Di Minno, Matteo Nicola Dario ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CENTRO CARDIOLOGICO MONZINO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ARTERIAL WALL THICKNESS; ARTICLE; ATTRIBUTABLE RISK; CAROTID ARTERY PULSE; CAROTID ATHEROSCLEROSIS; COMMON CAROTID ARTERY; DISEASE ASSOCIATION; HUMAN; HYPERCHOLESTEROLEMIA; PREVALENCE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; VITAMIN D DEFICIENCY;

EID: 85023174039     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2017-00342     Document Type: Article

References (53)

1. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM; Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911-1930.
2. Ng LL, Sandhu JK, Squire IB, Davies JE, Jones DJ. Vitamin D and prognosis in acute myocardial infarction. Int J Cardiol. 2013; 168(3):2341-2346.
3. Goleniewska B, Kacprzak M, Zielínska M. Vitamin D level and extent of coronary stenotic lesions in patients with first acute myocardial infarction. Cardiol J. 2014;21(1):18-23.
4. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, Benjamin EJ, D'Agostino RB, Wolf M, Vasan RS. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008; 117(4):503-511.
5. Zittermann A, Prokop S. The role of vitamin D for cardiovascular disease and overall mortality. Adv Exp Med Biol. 2014;810: 106-119.
6. Lee JH, O'Keefe JH, Bell D, Hensrud DD, Holick MF. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol. 2008;52(24):1949-1956.
7. Al Mheid I, Patel RS, Tangpricha V, Quyyumi AA. Vitamin D and cardiovascular disease: is the evidence solid? Eur Heart J. 2013; 34(48):3691-3698.
8. Chowdhury R, Kunutsor S, Vitezova A, Oliver-Williams C, Chowdhury S, Kiefte-de-Jong JC, Khan H, Baena CP, Prabhakaran D, Hoshen MB, Feldman BS, Pan A, Johnson L, Crowe F, Hu FB, Franco OH. Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ. 2014;348:g1903.
9. Norman PE, Powell JT. Vitamin D and cardiovascular disease. Circ Res. 2014;114(2):379-393.
10. Wang L, Ma J, Manson JE, Buring JE, Gaziano JM, Sesso HD. A prospective study of plasma vitamin D metabolites, vitamin D receptor gene polymorphisms, and risk of hypertension in men. Eur J Nutr. 2013;52(7):1771-1779.
11. Dong J, Wong SL, Lau CW, Lee HK, Ng CF, Zhang L, Yao X, Chen ZY, Vanhoutte PM, Huang Y. Calcitriol protects renovascular function in hypertension by down-regulating angiotensin II type 1 receptors and reducing oxidative stress. Eur Heart J. 2012;33(23): 2980-2990.
12. Canning MO, Grotenhuis K, de Wit H, Ruwhof C, Drexhage HA. 1-alpha,25-Dihydroxyvitamin D3 (1,25(OH)(2)D(3)) hampers the maturation of fully active immature dendritic cells from monocytes. Eur J Endocrinol. 2001;145(3):351-357.
13. Guillot X, Semerano L, Saidenberg-Kermanac'h N, Falgarone G, Boissier MC. VitaminDand inflammation. Joint Bone Spine. 2010; 77(6):552-557.
14. Takeda M, Yamashita T, Sasaki N, Nakajima K, Kita T, Shinohara M, Ishida T, Hirata K. Oral administration of an active form of vitamin D3 (calcitriol) decreases atherosclerosis in mice by inducing regulatory T cells and immature dendritic cells with tolerogenic functions. Arterioscler Thromb Vasc Biol. 2010;30(12): 2495-2503.
15. Al Mheid I, Patel R, Murrow J, Morris A, Rahman A, Fike L, Kavtaradze N, Uphoff I, Hooper C, Tangpricha V, Alexander RW, Brigham K, Quyyumi AA. Vitamin D status is associated with arterial stiffness and vascular dysfunction in healthy humans. J Am Coll Cardiol. 2011;58(2):186-192.
16. Bots ML, Grobbee DE. Intima media thickness as a surrogate marker for generalised atherosclerosis. Cardiovasc Drugs Ther. 2002;16(4):341-351.
17. de Groot E, Hovingh GK, Wiegman A, Duriez P, Smit AJ, Fruchart JC, Kastelein JJ. Measurement of arterial wall thickness as a surrogatemarker for atherosclerosis. Circulation. 2004;109(23, Suppl 1) III33-III38.
18. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr; Cardiovascular Health Study Collaborative Research Group. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. NEngl J Med. 1999;340(1):14-22.
19. Chambless LE, Heiss G, Folsom AR, Rosamond W, Szklo M, Sharrett AR, Clegg LX. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol. 1997;146(6):483-494.
20. Belcaro G, Nicolaides AN, Ramaswami G, Cesarone MR, De Sanctis M, Incandela L, Ferrari P, Geroulakos G, Barsotti A, Griffin M, Dhanjil S, Sabetai M, Bucci M, Martines G. Carotid and femoral ultrasound morphology screening and cardiovascular events in low risk subjects: a 10-year follow-up study (the CAFES-CAVE study (1)). Atherosclerosis. 2001;156(2):379-387.
21. Bhadra R, Choudhuri AR, Hazra A, Mukhopadhyay JD. Serum vitamin D level and its relation with carotid intima-media thickness in type 2 diabetic patients: a cross-sectional observational study. Diabetes Metab Syndr. 2016;10(2, Suppl 1)S55-S59.
22. Oz F, Cizgici AY, Oflaz H, Elitok A, Karaayvaz EB, Mercanoglu F, Bugra Z, Omer B, Adalet K, Oncul A. Impact of vitamin D insufficiency on the epicardial coronary flow velocity and endothelial function. Coron Artery Dis. 2013;24(5):392-397.
23. Dadoniene J, Cypiene A, Rinkuniene E, Badariene J, Burca J, Sakaite I, Kalinauskaite G, Kumpauskaite V, Laucevicius A. Vitamin D and functional arterial parameters in postmenopausal women with metabolic syndrome. Adv Med Sci. 2016;61(2): 224-230.
24. Winckler K, Tarnow L, Lundby-Christensen L, Almdal TP, Wiinberg N, Eiken P, Boesgaard TW; CIMT Trial Group. Vitamin D, carotid intima-media thickness and bone structure in patients with type 2 diabetes. Endocr Connect. 2015;4(2):128-135.
25. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.
26. Jüni P, Witschi A, Bloch R, Egger M. The hazards of scoring the quality of clinical trials for meta-analysis. JAMA. 1999;282(11): 1054-1060.
27. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557-560.
28. Sterne JA, Egger M, Smith GD. Systematic reviews in health care: investigating and dealing with publication and other biases in metaanalysis. BMJ. 2001;323(7304):101-105.
29. Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in metaanalysis. Biometrics. 2000;56(2):455-463.
30. Kang JY, Kim MK, Jung S, Shin J, Choi BY. The cross-sectional relationships of dietary and serum vitamin D with cardiometabolic risk factors: metabolic components, subclinical atherosclerosis, and arterial stiffness. Nutrition. 2016;32(10):1048-1056. e1.
31. Ameri P, Canepa M, Fabbi P, Leoncini G, Milaneschi Y, Mussap M, AlGhatrif M, Balbi M, Viazzi F, Murialdo G, Pontremoli R, Brunelli C, Ferrucci L. Vitamin D modulates the association of circulating insulin-like growth factor-1 with carotid artery intimamedia thickness. Atherosclerosis. 2014;236(2):418-425.
32. Blondon M, Sachs M, Hoofnagle AN, Ix JH, Michos ED, Korcarz C, Gepner AD, Siscovick DS, Kaufman JD, Stein JH, KestenbaumB, de Boer IH. 25-Hydroxyvitamin D and parathyroid hormone are not associated with carotid intima-media thickness or plaque in the multi-ethnic study of atherosclerosis. Arterioscler Thromb Vasc Biol. 2013;33(11):2639-2645.
33. Chen RH, Jiang XZ, Jiang Q, Gu Z, Gu PL, Zhou B, Zhu ZH, Xu LY, Zou YF. Correlations between serum levels of 25-hydroxyvitamin D and carotid atherosclerosis in patients with type 2 diabetes in Shanghai. Ann Endocrinol (Paris). 2014;75(4): 206-212.
34. Cheraghi N, Dai H, Raghuveer G. Vitamin D deficiency is associated with atherosclerosis-promoting risk factor clustering but not vascular damage in children. Med Sci Monit. 2012;18(12): CR687-CR692.
35. Ezzat YA, Sayed SB, Gaber WB, Mohey AMC, Kassem TWD. 25-Hydroxy vitamin D levels and its relation to disease activity and cardiovascular risk factors in women with systemic lupus erythematosus. The Egyptian Rheumatologist. 2011;33(4):195-201.
36. Gurses KM, Tokgozoglu L, Yalcin MU, Kocyigit D, Dural M, Canpinar H, Yorgun H, Sahiner ML, Kaya EB, Akin S, Gurlek A, Guc D, Aytemir K. Markers of subclinical atherosclerosis in premenopausal women with vitaminD deficiency and effect of vitamin D replacement. Atherosclerosis. 2014;237(2):784-789.
37. Hamdy Al-Said N, Abd El Ghaffar Mohamed N, Salam RF, Fawzy MW. Vitamin D as a risk factor for premature atherosclerosis in patients with type 2 diabetes. Ther Adv Endocrinol Metab. 2015; 6(6):249-257.
38. Jung JY, Koh BR, Bae CB, Kim HA, Suh CH. Carotid subclinical atherosclerosis is associated with disease activity but not vitamin D in Korean systemic lupus erythematosus. Lupus. 2014;23(14): 1517-1522.
39. Ma H, Lin H, Hu Y, Li X, He W, Jin X, Gao J, Zhao N, Liu Z, Gao X. Serum 25-hydroxyvitamin D levels are associated with carotid atherosclerosis in normotensive and euglycemic Chinese postmenopausal women: the Shanghai Changfeng study. BMC Cardiovasc Disord. 2014;14:197.
40. Portilla J, Moreno-Pérez O, Serna-Candel C, Escón C, Alfayate R, Reus S, Merino E, Boix V, Giner L, Sánchez-Payá J, Pićo A. Vitamin D insufficiency and subclinical atherosclerosis in non-diabetic males living with HIV. J Int AIDS Soc. 2014; 17:18945.
41. Robinson AB, Tangpricha V, Yow E, Gurion R, McComsey GA, Schanberg LE; APPLE Investigators. Vitamin D deficiency is common and associated with increased C-reactive protein in children and young adults with lupus: an Atherosclerosis Prevention in Pediatric Lupus Erythematosus substudy. Lupus Sci Med. 2014;1(1):e000011.
42. Sachs MC, Brunzell JD, Cleary PA, Hoofnagle AN, Lachin JM, Molitch ME, Steffes MW, Zinman B, de Boer IH; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group. Circulating vitamin D metabolites and subclinical atherosclerosis in type 1 diabetes. Diabetes Care. 2013;36(8):2423-2429.
43. Serra-Planas E, Aguilera E, Granada ML, Soldevila B, Salinas I, Reverter JL, Pizarro E, Pellitero S, Alonso N, Mauricio D, Puig-Domingo M. High prevalence of vitamin D deficiency and lack of association with subclinical atherosclerosis in asymptomatic patients with type 1 diabetes mellitus from aMediterranean area. Acta Diabetol. 2015;52(4):773-779.
44. Targher G, Bertolini L, Padovani R, Zenari L, Scala L, Cigolini M, Arcaro G. Serum 25-hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients. Clin Endocrinol (Oxf). 2006;65(5):593-597.
45. van de Luijtgaarden KM, Voûte MT, Hoeks SE, Bakker EJ, Chonchol M, Stolker RJ, Rouwet EV, Verhagen HJ. Vitamin D deficiency may be an independent risk factor for arterial disease. Eur J Vasc Endovasc Surg. 2012;44(3):301-306.
46. Yadav AK, Banerjee D, Lal A, Jha V. Vitamin D deficiency, CD4+CD28null cells and accelerated atherosclerosis in chronic kidney disease. Nephrology (Carlton). 2012;17(6):575-581.
47. Di Minno MN, Di Minno A, Songia P, Ambrosino P, Gripari P, Ravani A, Pepi M, Rubba PO, Medda E, Tremoli E, Baldassarre D, Poggio P. Markers of subclinical atherosclerosis in patients with aortic valve sclerosis: a meta-analysis of literature studies. Int J Cardiol. 2016;223:364-370.
48. Ford JA, MacLennan GS, Avenell A, Bolland M, Grey A, Witham M; RECORD Trial Group. Cardiovascular disease and vitamin D supplementation: trial analysis, systematic review, and metaanalysis. Am J Clin Nutr. 2014;100(3):746-755.
49. Heaney RP. Guidelines for optimizing design and analysis of clinical studies of nutrient effects. Nutr Rev. 2014;72(1):48-54.
50. Heaney RP, French CB, Nguyen S, Ferreira M, Baggerly LL, Brunel L, Veugelers P. A novel approach localizes the association of vitamin D status with insulin resistance to one region of the 25-hydroxyvitamin D continuum. Adv Nutr. 2013;4(3):303-310.
51. Hardiman G, Savage SJ, Hazard ES, Wilson RC, Courtney SM, Smith MT, Hollis BW, Halbert CH, Gattoni-Celli S. Systems analysis of the prostate transcriptome in African-American men compared with European-American men. Pharmacogenomics. 2016;17(10):1129-1143.
52. Al-Garawi A, Carey VJ, Chhabra D, Mirzakhani H, Morrow J, Lasky-Su J, Qiu W, Laranjo N, Litonjua AA, Weiss ST. The role of vitamin D in the transcriptional program of human pregnancy. PLoS One. 2016;11(10):e0163832.
53. Achterberg C. A commentary on evidence-based analysis. Nutr Today. 2013;48(4):153-160.